(66 days)
None
No
The document describes a calibration system for a blood gas analyzer and does not mention any AI or ML components.
No
The device is described as an in vitro diagnostic product for the calibration of analytes, which is used for measurement and not for treating or diagnosing a disease.
No
Explanation: The provided text describes the RAPIDPoint® 500 System measurement cartridge with calibrators as an "in vitro diagnostic product for the calibration of the analytes" on the RAPIDPoint® 500 System. It explicitly states it is for calibration, not for directly diagnosing a condition in a patient. While it's used with a diagnostic system, the device itself is a calibrator.
No
The device description explicitly states it consists of physical components (measurement cartridge, wash/waste cartridge) containing calibrators and reagents, indicating it is a hardware-based in vitro diagnostic product, not software-only.
Yes, this device is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section explicitly states: "The RAPIDPoint® 500 System measurement cartridge with calibrators is an in vitro diagnostic product for the calibration of the analytes on the RAPIDPoint® 500 System."
This statement directly identifies the device as an in vitro diagnostic product.
N/A
Intended Use / Indications for Use
The RAPIDPoint® 500 System measurement cartridge with calibrators is an in vitro diagnostic product for the calibration of the analytes on the RAPIDPoint® 500 System. The analytes measured are partial pressure of carbon dioxide (pCO2), partial pressure of oxygen (pO2), pH, Sodium (Na+), Potassium (K+), ionized Calcium (Ca++), Chloride (Cl-), Glucose (Glu), total hemoglobin (tHb), Neonatal Bilirubin and Lactate (Lac).
Product codes
JIX
Device Description
The RAPIDPoint® 500 System consists of four (4) calibrators contained in the measurement cartridge and wash/waste cartridge that are used to calibrate the following analytes: pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), Sodium (Na ), Potassium (K ), ionized Calcium (Ca *), Chloride (Cl), Glucose (Glu), total hemoglobin (tHb) and Lactate (Lac). There is no unique calibration measurement for Neonatal Bilirubin (nBili) as the tHb calibration is used.
The measurement cartridge contains the following calibrators: 200 Cal, Reagent C and Low Sulfite Zero Cal. The wash/waste cartridge contains the wash reagent.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The calibrator target levels, protocol, value assignment procedure, acceptance criteria. stability and traceability for the following analytes: pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), Sodium, (Na*), Potassium (K*), ionized Calcium (Ca**), Chloride (Cl7), Glucose (Glu) , total hemoglobin (tHb) and Lactate (Lac) have been validated following procedures of Siemens Healthcare Diagnostics Inc. Point-of-Care Business Unit. There is no unique calibration measurement for nBili as the tHb calibration is used.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
///.///
65.
510(k) Summary
に
OCT 12 2012
510(k) Summary of Safety and Effectiveness for the RAPIDPoint 500 System Cartridge Calibrators
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
A. 510(k) Number: K122398
B. Date of Preparation: October 10, 2012
- C. Proprietary and Established Names: RAPIDPoint® 500 System Measurement Cartridge with Calibrators
D. Applicant:
Siemens Healthcare Diagnostics Inc., Point-of-Care Business Unit 2 Edgewater Drive Norwood, MA 02062 Primary Contact: Amy Goldberg, Technical Specialist, Regulatory Affairs Tel: (781) 269-3544 Fax: (781) 269-3210
Secondary Contact: Noor Malki, Vice President, Clinical, Regulatory and Quality Tel: (781) 269-3401 Fax: (781) 269-3210
E. Requlatory Information:
-
- Regulation Section: 21 CFR § 862.1150 Calibrator
-
- Classification: Class II
-
- Product Code: JIX calibrator, multi-analyte mixture
-
- Panel: Clinical Chemistry
F. Predicate Device:
The predicate device used to demonstrate substantial equivalence is the Dimension Vista® LOCI 7 Calibrator, Models: K6456 and KC605, cleared under K100344.
G. Device Description:
The RAPIDPoint® 500 System consists of four (4) calibrators contained in the measurement cartridge and wash/waste cartridge that are used to calibrate the following analytes: pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), Sodium (Na ), Potassium (K ), ionized Calcium (Ca *), Chloride (Cl), Glucose (Glu), total hemoglobin (tHb) and Lactate (Lac). There is no unique calibration measurement for Neonatal Bilirubin (nBili) as the tHb calibration is used.
The measurement cartridge contains the following calibrators: 200 Cal, Reagent C and Low Sulfite Zero Cal. The wash/waste cartridge contains the wash reagent.
1
510(k) Summary
دب م
ଦ
H. Intended Use:
The RAPIDPoint® 500 System measurement cartridge with calibrators is an in vitro diagnostic product for the calibration of the analytes on the RAPIDPoint® 500 System. The analytes measured are partial pressure of carbon dioxide (pCO2), partial pressure of oxygen (pO2), pH, Sodium (Na ), Potassium (K'), ionized Calcium (Ca), Chloride (Cl), Glucose (Glu), total hemoglobin (tHb), Neonatal Bilirubin (nBili) and Lactate (Lac).
I. Substantial Equivalence Information:
The RAPIDPoint® 500 System measurement cartridge with calibrators was compared to the predicate device, Dimension Vista® LOCI 7 Calibrator. The following table provides the similarities and differences
| Feature | Device
RAPIDPoint® 500 System
Measurement Cartridge with
Calibrators | Predicate Device
Dimension Vista®
LOCI 7 Calibrator
K100344 |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | The RAPIDPoint® 500 System
measurement cartridge with
calibrators is an in vitro
diagnostic product for the
calibration of the analytes on the
RAPIDPoint® 500 System. The
analytes measured are partial
pressure of carbon dioxide
(pCO2), partial pressure of
oxygen (pO2), pH, Sodium (Na+),
Potassium (K+), ionized Calcium
(Ca++), Chloride (Cl-), Glucose
(Glu), total hemoglobin
(tHb), Neonatal Bilirubin
(nBili) and Lactate (Lac). | The LOCI 7 CAL is an
in vitro diagnostic
product for the
calibration of Cancer
Antigen 15-3 (CA 15-3)
and Cancer Antigen 19-
9 (CA 19-9) methods on
the Dimension Vista®
system. |
| Matrix | Aqueous salt solution | Bovine Serum Albumin |
| Format/Preparation | Liquid | Same |
| Storage/Shelf-life | Store at 2 to 8°C | Store at -25 to -15°C |
2
510(k) Summary
تر
ﺗﻘ
J . Traceability:
.
| Analyte | Traceability Method |
|---|---|
| pH | Traceable to NIST SRM186 reference materials |
| via the IFCC blood reference method. | |
| pCO2 | Traceable to tonometered aqueous standards |
| prepared using NIST traceable temperature and | |
| pressure standards and gravimetrically prepared | |
| precision gas standards. | |
| pO2 | Traceable to tonometered aqueous standards |
| prepared using NIST traceable temperature and | |
| pressure standards and gravimetrically prepared | |
| precision gas standards. | |
| K+ | Traceable to NIST SRM 918 reference materials |
| using flame photometry. | |
| Na+ | Traceable to NIST SRM 919 reference material |
| using flame photometry. | |
| Ca++ | Traceable to gravimetrically prepared internal |
| standards using NIST SRM 915 and ISE methods | |
| embodied in Siemens blood gas analyzers. | |
| Cl- | Traceable to NIST SRM 919 or 918 reference |
| materials using a Coulometric reference method. | |
| Glucose | Traceable to NIST SRM 917 reference materials |
| using the Hexokinase method. | |
| tHb | Traceable to internal standards calibrated against |
| the CLSI Cyanmethemoglobin method. | |
| Lactate | Traceable to high purity lactate using the Lactate |
| dehydrogenase spectrophotometric method. | |
| Neonatal | |
| Bilirubin | There is no unique calibrator for nBili. It is an |
| optical measurement that is associated with tHb, | |
| which is traceable as noted above. |
K. Value Assignment:
Calibrator values are assigned by multiple measurements using multiple test systems such a flame photometry, mass spectrometry and others.
3
510(k) Summary - Revised
L. Stability:
The stability protocols and acceptance criteria were included and testing data met predetermined acceptance criteria. The following table lists the stability/shelf life for each calibrator:
| Calibrator | Stability/Shelf Life |
|---|---|
| 200 Cal | 12 months at 2° to 8°C |
| Low Sulfite Zero Cal | |
| (LSZC) | 12 months at 2° to 8°C |
| Reagent C | 15 months at 2° to 30°C |
M. Performance Characteristics:
The calibrator target levels, protocol, value assignment procedure, acceptance criteria. stability and traceability for the following analytes: pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), Sodium, (Na*), Potassium (K*), ionized Calcium (Ca**), Chloride (Cl7), Glucose (Glu) , total hemoglobin (tHb) and Lactate (Lac) have been validated following procedures of Siemens Healthcare Diagnostics Inc. Point-of-Care Business Unit. There is no unique calibration measurement for nBili as the tHb calibration is used.
N. Conclusion:
The RAPIDPoint® 500 System measurement cartridge with calibrators is substantially equivalent to the Dimension Vista® LOCI 7 Calibrator previously cleared under K100344.
Siemens Healthcare Diagnostics - Point-of-Care (POC) Business Unit RAPIDPoint 500 Calibrators / Traditional 510(k)
Vol. 1, Page 4 of 4
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus symbol.
Food and Drug Administration
10903 New Hampshire Avenue Silver Spring, MD 20993
Siemens Healthcare Diagnostics, Inc. c/o Amy Goldberg 2 Edgewater Drive Norwood, MA 02062
OCT 1 2 2012
Re: K122398
Trade Name: RAPIDPoint® 500 System Measurement Cartridge with Calibrators Regulation Number: 21 CFR §862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Codes: JIX Dated: August 6, 2012 Received: August 7, 2012
Dear Ms. Goldberg:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
5
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please 11 you a sen o effice of In Vitro Diagnostic Devices and Radiological Health at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" Also, productions the regarding regarding postmarket surveillance, please contact CDRH'S (21 CL Par of Surveillance and Biomeric's (OSB's) Division of Postmarket Surveillance at (301) 796-576-. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance ...
You may obtain other general information on your responsibilities under the Act from the I va may of Small Manufacturers, International and Consumer Assistance at its toll-free number (800 638-2041 or (301) 796-5680 or at its Internet address http://www.fda/gov/MedicalDevices/ResourcesforYou/Industry/default.htm
Sincerely yours,
Sincerely yours,
Courtney H. Lias, Ph.D Director Division of Chemistry and Toxicology Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
6
Indications for Use Form
510(k) Number (if known): K122398
Device Name: RAPIDPoint® 500 System Measurement Cartridge with Calibrators
Intended Use:
The RAPIDPoint® 500 System measurement cartridge with calibrators is an in vitro diagnostic product for the calibration of the analytes on the RAPIDPoint® 500 System. The analytes measured are partial pressure of carbon dioxide (pCO2), partial pressure of oxygen (pO2), pH, Sodium (Na*), Potassium (K*), ionized Calcium (Ca**), Chloride (Cl7), Glucose (Glu), total hemoglobin (tHb), Neonatal Bilirubin and Lactate (Lac).
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Yung Chan
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
K122398 510(k).